SCHEMBL7744678

SCHEMBL7744678

CC(=O)Nc1cnco1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4429605 0.79
SCHEMBL29479737 0.73 DYRK1A (0.48)
SCHEMBL84748 0.70
SCHEMBL28985219 0.70 KMT2A (0.67)
SCHEMBL22823023 0.70 SMN1; SMN2 (0.58)
SCHEMBL28286237 0.69 NPC1 (0.33)
SCHEMBL3262016 0.67 TDP1 (0.52)
SCHEMBL31078239 0.66
SCHEMBL13165611 0.66 KMT2A (0.64)
SCHEMBL27458469 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed
EP-0138464-B1 2-AMINO-5-HYDROXY-4-METHYLPYRIMIDINE DERIVATIVES PFIZER INC. (US) 1989-11-15 EP disclosed
US-4673677-A 2-AMINO-5-HYDROXY-4-METHYLPYRIMIDINE PFIZER INC. (US) 1987-06-16 US disclosed
US-4554276-A ENZYME INHIBITORS, ANTIULCER AGENTS PFIZER INC. (US) 1985-11-19 US disclosed
EP-0138464-A2 2-Amino-5-hydroxy-4-methylpyrimidine derivatives PFIZER INC. (US) 1985-04-24 EP disclosed